Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance. | Cancers (Basel) | 2023 | 38136293 | PubTator, text mining | PubMed |
| Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic review. | Neurooncol Adv | 2023 | 38130901 | PubTator, text mining | PubMed |
| Detection of Modified Histones from Oral Mucosa of a Patient with DYT-KMT2B Dystonia. | Mol Syndromol | 2023 | 38108041 | PubTator, text mining | PubMed |
| Nanopore Single-molecule Analysis of Biomarkers: Providing Possible Clues to Disease Diagnosis. | Trends Analyt Chem | 2023 | 38106545 | PubTator, text mining | PubMed |
| Deep computational phenotyping of genomic variants impacting the SET domain of KMT2C reveal molecular mechanisms for their dysfunction. | Front Genet | 2023 | 38090150 | PubTator, text mining | PubMed |
| Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma. | Heliyon | 2023 | 38076205 | PubTator, text mining | PubMed |
| An extremely rare case of recurrent pleomorphic myxoidliposarcoma with response to eribulin chemotherapy - A case report. | Rare Tumors | 2023 | 38074447 | PubTator, text mining | PubMed |
| The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. | Exp Hematol Oncol | 2023 | 38066523 | PubTator, text mining | PubMed |
| Comparison of Clinico-Demographic and Histological Parameters Between Young and Old Patients With Oral Squamous Cell Carcinoma. | Cureus | 2023 | 38046721 | PubTator, text mining | PubMed |
| Efficient generation of brain organoids using magnetized gold nanoparticles. | Sci Rep | 2023 | 38040919 | PubTator, text mining | PubMed |
| Protein intrinsically disordered regions have a non-random, modular architecture. | Bioinformatics | 2023 | 38039154 | PubTator, text mining | PubMed |
| The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback. | Cell Commun Signal | 2023 | 38037054 | PubTator, text mining | PubMed |
| Tumor-suppressive functions of protein lysine methyltransferases. | Exp Mol Med | 2023 | 38036730 | PubTator, text mining | PubMed |
| A Systems Biology Approach for Investigating Significant Biomarkers and Drug Targets Common Among Patients with Gonorrhea, Chlamydia, and Prostate Cancer: A Pilot Study. | Bioinform Biol Insights | 2023 | 38033384 | PubTator, text mining | PubMed |
| SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report. | Gynecol Oncol Rep | 2023 | 38033359 | PubTator, text mining | PubMed |
| Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 38028538 | PubTator, text mining | PubMed |
| Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective. | Front Neurosci | 2023 | 38027472 | PubTator, text mining | PubMed |
| Genomic profiling and immune landscape of olfactory neuroblastoma in China. | Front Oncol | 2023 | 38023213 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | Genome Biol | 2023 | 38012744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers?page=9